12 träffar

DrugACE inhibitor
Enalapril

Renitec Enalapril Sandoz ACE inhibitor Prodrug hydrolysed to enalaprilat. Reduces mortality in heart failure with reduced ejection fraction — the effect is dose-dependent, and underdosing…

DrugUltra-short-acting β₁-selective blocker
Esmolol

Brevibloc Ultra-short-acting β₁-selective blocker The beta-blocker to choose when reversibility matters. With a half-life of 9 minutes and the effect…

DrugAngiotensin II receptor blocker (ARB)
Candesartan

…in heart failure (CHARM), and the first choice when an ACE inhibitor must be switched due to cough. The target dose in heart failure is…

DrugIndirect thrombin and factor Xa inhibitor via antithrombin
Heparin (unfractionated)

…be neutralised completely with protamine within minutes. This is why unfractionated heparin is the first choice in severe renal failure, in the bleeding-prone patient…

DrugAminopenicillin with extended Gram-negative spectrum
Amoxicillin

…determines its use. Amoxicillin is therefore not first-line for uncomplicated acute otitis media — that role belongs to phenoxymethylpenicillin — but for treatment failure, recurrent otitis…

DrugLong-acting dihydropyridine calcium channel blocker
Amlodipine

…cornerstone drug for hypertension and stable angina, and the easiest calcium channel blocker to use: once-daily dosing, a half-life of almost two days…

DrugHighly selective β₁-blocker
Bisoprolol

…blockers, with documented mortality benefit in heart failure from CIBIS-II. Bioavailability is close to 90 % and elimination is equally shared between liver and kidney…

DrugSGLT2 inhibitor
Empagliflozin

…reduced heart failure events regardless of ejection fraction in EMPEROR-Reduced and EMPEROR-Preserved, and slowed renal function decline down to eGFR 20 in EMPA…

DrugLoop diuretic
Furosemide

…curve, not a line: below the threshold nothing happens, and in renal failure the threshold dose must be raised to achieve any effect at all.

DrugSGLT2 inhibitor
Dapagliflozin

…extends well beyond the diabetes indication. DAPA-HF demonstrated reduced cardiovascular death and worsening heart failure with reduced ejection fraction, DELIVER showed equivalent benefit with…

DrugNon-selective COX inhibitor with COX-2 predominance, phenylacetic acid derivative
Diclofenac

…and heart failure resembles that of selective COX-2 inhibitors and is seen already at doses below 100 mg/day and with short treatment duration…

DrugSelective If-channel inhibitor in the sinus node
Ivabradine

…symptomatic patient with HFrEF who remains above 70 beats per minute despite maximally tolerated beta-blockade, where SHIFT demonstrated reduced risk of heart failure hospitalisation.